MINNEAPOLIS, June 03, 2024 Celcuity Inc. , a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its participation in the Jefferies.
Celcuity (NASDAQ:CELC) Stock Price Up 8.1% modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Celcuity Announces Pricing of Underwritten Common Stock Offering marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line ... eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reissued their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a report released on Thursday morning, Benzinga reports. They currently have a $27.00 price objective on the stock. HC Wainwright also issued estimates for Celcuity’s FY2028 earnings at $4.08 EPS. A number of other analysts also recently weighed in on […]
Craig Hallum reissued their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a research note issued to investors on Thursday, Marketbeat.com reports. The firm currently has a $27.00 target price on the stock, up from their previous target price of $25.00. Several other research firms have also commented on CELC. Needham & […]
Stifel Nicolaus reissued their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a report published on Thursday morning, Benzinga reports. They currently have a $40.00 price objective on the stock. A number of other research firms have also issued reports on CELC. Needham & Company LLC reissued a buy rating and set […]
HC Wainwright Equities Analysts Decrease Earnings Estimates for Celcuity Inc. (NASDAQ:CELC) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Celcuity (NASDAQ:CELC – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Needham & Company LLC in a report issued on Thursday, Benzinga reports. They presently have a $24.00 price target on the stock. Needham & Company LLC’s target price points to a potential upside of 39.29% from the stock’s […]
Operator: Good afternoon, ladies and gentlemen. And welcome the Celcuity First Quarter 2024 Financial Results Conference call. At this time, all lines are in a listen-only mode.